Encapsulation of temozolomide in a tumor-targeting nanocomplex enhances anti-cancer efficacy and reduces toxicity in a mouse model of glioblastoma

Cancer Letters
Sang-Soo KimEsther H Chang

Abstract

Although temozolomide (TMZ) is the current first-line chemotherapy for glioblastoma multiforme (GBM), most patients either do not respond or ultimately fail TMZ treatment. Both intrinsic tumor resistance and limited access of TMZ to brain tumors as a result of the blood-brain barrier (BBB) contribute to poor response and ultimately to poor prognosis for GBM patients. We have developed a "dual-targeting" nanomedicine that both actively crosses the BBB and actively targets cancer cells once in the brain parenchyma. This nanomedicine (termed scL-TMZ) is sized ~40 nm and comprised of a cationic liposome (DOTAP:DOPE) encapsulating TMZ. The surface of liposome is decorated with anti-transferrin receptor single-chain antibody fragments to facilitate the crossing of the BBB by the scL-TMZ in addition to targeting GBM in the brain. This novel formulation was found to be markedly more effective than standard TMZ in both TMZ-resistant and TMZ-sensitive GBM. Encapsulation of TMZ also markedly enhanced its efficacy in killing a variety of non-GBM tumor cells. The scL-TMZ nanocomplex was shown to target cancer stem cells, which have been linked to both drug resistance and recurrence in GBM. Most significantly, systemically administered scL-T...Continue Reading

References

Aug 8, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·L XuE H Chang
Aug 22, 2006·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Tracy R DanielsManuel L Penichet
Jul 11, 2007·Pharmaceutical Research·Angela R Jones, Eric V Shusta
Feb 8, 2008·International Journal of Pharmaceutics·Guihua HuangMingjin Dou
Apr 3, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kathleen F PirolloEsther H Chang
Sep 23, 2008·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Karsten UlbrichJörg Kreuter
Jan 20, 2009·Current Medicinal Chemistry·Lucio Tentori, Grazia Graziani
Aug 12, 2009·Journal of Neuro-oncology·A BerrocalUNKNOWN GENOM Cooperative Group
Oct 12, 2010·Expert Review of Neurotherapeutics·Marc C Chamberlain
Mar 15, 2011·International Journal of Oncology·Susan NoellRainer Ritz
Oct 13, 2011·Molecular Cancer·Dagmar BeierChristoph P Beier
Jan 11, 2012·Methods in Enzymology·William M Pardridge, Ruben J Boado
Mar 24, 2012·Neurosurgery Clinics of North America·Daniel T NagasawaIsaac Yang
Apr 26, 2012·Molecular Cancer Therapeutics·Shinji KohsakaShinya Tanaka
Jul 24, 2012·Cancer Treatment Reviews·Zuzana TatarXavier Durando
Nov 8, 2012·Clinical & Developmental Immunology·Sadhak SenguptaPrakash Sampath
Apr 24, 2013·Molecular Therapy : the Journal of the American Society of Gene Therapy·Neil SenzerEsther H Chang
Nov 30, 2013·Pharmaceuticals·Yulian P RamirezAlonzo H Ross
Feb 15, 2014·World Journal of Clinical Oncology·Wei ZhuPing Liu

❮ Previous
Next ❯

Citations

Jan 16, 2016·Nanomedicine : Nanotechnology, Biology, and Medicine·Guido Frosina
Jan 11, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Efstathios Karathanasis, Ketan B Ghaghada
May 28, 2016·Journal of Nanobiotechnology·Ewelina PiktelRobert Bucki
Dec 24, 2016·ACS Applied Materials & Interfaces·Vuk UskokovićVictoria M Wu
Jan 25, 2018·International Journal of Molecular Sciences·Nausicaa ClementeChiara Dianzani
Nov 15, 2018·Journal of Translational Internal Medicine·Justin S MichaelJohn S Yu
Jun 2, 2016·Molecular Medicine·Yaghoub SafdariVahid Erfani-Moghadam
Nov 2, 2018·Recent Patents on Anti-cancer Drug Discovery·Maricruz Anaya-RuizMartín Pérez-Santos
Nov 2, 2019·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Chengkun YeHongmei Liu
Oct 11, 2017·Frontiers in Immunology·Rok RazpotnikUros Rajcevic
Nov 5, 2016·Wiley Interdisciplinary Reviews. Nanomedicine and Nanobiotechnology·Aniket S WadajkarAnthony J Kim
Jan 25, 2021·Advanced Drug Delivery Reviews·Taskeen Iqbal JanjuaAmirali Popat
Mar 28, 2021·Archivum Immunologiae Et Therapiae Experimentalis·Benita Ortega-BerlangaGabriela Navarro-Tovar
Mar 31, 2021·Neurosurgery Clinics of North America·Katherine E Kunigelis, Michael A Vogelbaum
Apr 4, 2021·Pharmaceutics·Giordano PeriniGiulio Caracciolo
Jan 9, 2019·Trends in Cancer·Luiz Henrique Medeiros GeraldoFlavia Regina Souza Lima
Apr 30, 2021·International Journal of Pharmaceutics·Solmaz Mojarad-JabaliHadi Valizadeh
Aug 8, 2021·Cancers·Phuong DoanMeenakshisundaram Kandhavelu
Oct 26, 2018·Molecular Pharmaceutics·Sarah M WardTodd Emrick
Oct 9, 2018·ACS Chemical Biology·Riley L SvecPaul J Hergenrother
Jul 18, 2018·ACS Chemical Neuroscience·Antonietta ArcellaGiulio Caracciolo
Aug 31, 2021·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Leonardo Delello Di FilippoMarlus Chorilli

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Cancer Cell Invasion: Nanomedicine

Nanomedicine is a promising alternative for cancer detection and therapy that utilizes nanoparticles, such as liposomes. Nanoparticles can potentially target cancer cell invasion and metastasis. Discover the latest research on Cancer Cell Invasion: Nanomedicine here.